Resources

In This Together: CAS Joining Forces with Researchers and Data Scientists to Accelerate COVID-19 Treatments

With millions of confirmed COVID-19 cases, and many more likely going untested, researchers around the world are racing to find solutions to this daunting challenge. Approved drugs are being explored as treatments for those afflicted, vaccines to prevent the long-term spread are in development, as well as many other efforts beyond drug discovery. To keep frontline healthcare professionals safe, manufacturers are reimagining production processes to make critical supplies, such as hand sanitizer and mask filters, testing methods are being optimized to be faster and more accurate, materials for new germ-resistant masks are being developed and new systems to sterilize medical equipment are being designed.

Beating COVID-19: Insights and strategies for new vaccines and therapies

The outbreak of COVID-19, caused by the new virus SARS-CoV-2, has spread rapidly across the world. Since the first report from Wuhan, China on December 31, 2019, the total numbers of confirmed cases and COVID-19-related deaths worldwide have continued to escalate. Now declared a pandemic by the World Health Organization (“WHO”), COVID-19 has already overwhelmed healthcare systems in many countries and is expected to impose a major impact on the world economy.

Recent advances support scalability of COVID-19 diagnostic testing

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, continues to grip the world. Large-scale testing is required for countries to successfully limit infections and mortality rates, and is key to easing many lockdown restrictions. In this unprecedented crisis, every hour matters when it comes to identifying and preventing further spread of this virus.

The Latest COVID-19 Vaccine Questions Answered

Answers to frequently asked questions regarding the safety, efficacy, and composition of the currently available Covid vaccines. Updated March 26, 2021.

Drugs approved by the FDA in 2020 reflect continuing trend of structural innovation

Classic and new technologies vying to be the first COVID-19 vaccine

Development of a COVID-19 vaccine remains a challenge. This article will review general vaccine approaches, and provide insight into the current COVID-19 vaccine pipeline.

3 must-haves for an effective sci-tech data strategy: Get started on the right foot

The path to a data strategy is one of continual improvement and is far from a one-and-done endeavor. Learning never ends but will pay back exponentially as you are able to accelerate innovation and unlock the true value of your rich R&D data. Learn how CAS can help you establish a structured data management strategy and draw valuable insights.

Launch of Pistoia Alliance Chemical Safety Library powered by CAS platform facilitates information sharing between scientists to improve laboratory safety

Launch of the Pistoia Alliance Chemical Safety Library, powered by a new CAS platform, facilitates information sharing between scientists to improve laboratory safety by providing access to critical crowd-sourced reaction hazard information to reduce incidents.

Find a better route: Optimizing AI for more novel synthetic predictions

AI and machine learning models aid in retrosynthetic planning, but are limited by the training data they have seen. Read on to learn about ways to generate novel predictions by ensuring your data has the necessary diversity and quality to optimize key synthetic planning initiatives.